ConductScience.org, home

Paper42100345

The role of pluripotency regulators in triple-negative breast cancer immune response.

López-Santana C and 2 others. Front Genet, 2026. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. The role of pluripotency regulators in triple-negative breast cancer immune response. Papers, record 42100345. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100345

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of pluripotency regulators in triple-negative breast cancer immune response.
PubMed
Journal
Front Genet
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1López-Santana CCarolina
2Mendez-Rivera FFabio
3Bernal-Estévez DADavid A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References120

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123926105
Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
J Biol Chem2013https://conductscience.org/library/papers/23926105PubMed
216710719Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.Cancer Immunol Immunother2007https://conductscience.org/library/papers/16710719PubMed
338505617Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer.Theranostics2024https://conductscience.org/library/papers/38505617PubMed
424799675Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24799675PubMed
535760778Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer.Nat Commun2022https://conductscience.org/library/papers/35760778PubMed
630035158Targeting MYC for triple-negative breast cancer treatment.Oncoscience2018https://conductscience.org/library/papers/30035158PubMed
735814205Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer.Front Pharmacol2022https://conductscience.org/library/papers/35814205PubMed
829750424Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.Int J Oncol2018https://conductscience.org/library/papers/29750424PubMed
931616443WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.Front Immunol2019https://conductscience.org/library/papers/31616443PubMed
1033256070Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/33256070PubMed
1125827713Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.Stem Cells2015https://conductscience.org/library/papers/25827713PubMed
1227539549The hedgehog pathway in triple-negative breast cancer.Cancer Med2016https://conductscience.org/library/papers/27539549PubMed
1341069341Therapeutic innovations in triple negative breast cancer: integrating molecular targeting and monoclonal antibody strategies.Front Oncol2025https://conductscience.org/library/papers/41069341PubMed
1423340294Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.Clin Cancer Res2013https://conductscience.org/library/papers/23340294PubMed
1539001543Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.Cancers (Basel)2024https://conductscience.org/library/papers/39001543PubMed
1631324052Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.Cancers (Basel)2019https://conductscience.org/library/papers/31324052PubMed
1738213533Targeting cancer stem cell plasticity in triple-negative breast cancer.Explor Target Antitumor Ther2023https://conductscience.org/library/papers/38213533PubMed
1831921137Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.Front Immunol2019https://conductscience.org/library/papers/31921137PubMed
1926727947Overexpression of sonic hedgehog in the triple negative breast cancer: clinicopathological characteristics of high burden breast cancer patients from Bangladesh.Sci Rep2016https://conductscience.org/library/papers/26727947PubMed
2031379945Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype.J Oncol2019https://conductscience.org/library/papers/31379945PubMed

See all 120 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42630934B-cells in breast cancer: current insights and challenges.Front Oncol2026https://conductscience.org/library/papers/42630934PubMed
42495706NUPR1 in breast cancer: mechanisms and potential applications.Front Physiol2026https://conductscience.org/library/papers/42495706PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42100345

GET https://conductscience.org/api/papers/v1/42100345/references?page=2